title: Occult hepatitis B virus infection and blood transfusion.
abstract: Transfusion-transmitted infections including hepatitis B virus (HBV) have been a major concern in transfusion medicine. Implementation of HBV nucleic acid testing (NAT) has revealed occult HBV infection (OBI) in blood donors. In the mid-1980s, hepatitis B core antibody (HBc) testing was introduced to screen blood donors in HBV non-endemic countries to prevent transmission of non-A and non-B hepatitis. That test remains in use for preventing of potential transmission of HBV from hepatitis B surface antigen (HBsAg)-negative blood donors, even though anti-hepatitis C virus tests have been introduced. Studies of anti-HBc-positive donors have revealed an HBV DNA positivity rate of 0%-15%. As of 2012, 30 countries have implemented HBV NAT. The prevalence of OBI in blood donors was estimated to be 8.55 per 1 million donations, according to a 2008 international survey. OBI is transmissible by blood transfusion. The clinical outcome of occult HBV transmission primarily depends on recipient immune status and the number of HBV DNA copies present in the blood products. The presence of donor anti-HBs reduces the risk of HBV infection by approximately five-fold. The risk of HBV transmission may be lower in endemic areas than in non-endemic areas, because most recipients have already been exposed to HBV. Blood safety for HBV, including OBI, has substantially improved, but the possibility for OBI transmission remains.
authors.affiliation: Dong Hee Seo, Labgenomics Clinical Laboratories, Seongnam-si 463-400, South Korea.
authors.forename: Dong Hee
authors.initials: DH
authors.lastname: Seo
authors.affiliation: Dong Hee Seo, Labgenomics Clinical Laboratories, Seongnam-si 463-400, South Korea.
authors.forename: Dong Hee
authors.initials: DH
authors.lastname: Whang
authors.affiliation: Dong Hee Seo, Labgenomics Clinical Laboratories, Seongnam-si 463-400, South Korea.
authors.forename: Eun Young
authors.initials: EY
authors.lastname: Song
authors.affiliation: Dong Hee Seo, Labgenomics Clinical Laboratories, Seongnam-si 463-400, South Korea.
authors.forename: Kyou Sup
authors.initials: KS
authors.lastname: Han
keywords: Anti-hepatitis B core antibody; Blood service; Nucleic acid testing; Occult hepatitis B infection; Transfusion
references.citation: Transfusion. 2012 Feb;52(2):440-6
references.pmid: 21810101
references.citation: Transfusion. 1997 Jun;37(6):634-40
references.pmid: 9191825
references.citation: J Hepatol. 2011 Nov;55(5):996-1003
references.pmid: 21376091
references.citation: Vox Sang. 2008 Feb;94(2):153-66
references.pmid: 18205672
references.citation: Haematologica. 2007 Dec;92(12):1664-70
references.pmid: 18055990
references.citation: Blood Transfus. 2015 Apr;13(2):227-32
references.pmid: 25369612
references.citation: Transfusion. 2010 Jan;50(1):65-74
references.pmid: 19709394
references.citation: Hepatology. 2006 Dec;44(6):1666-74
references.pmid: 17133474
references.citation: J Immunol Methods. 1999 Nov 19;230(1-2):29-35
references.pmid: 10594351
references.citation: Vox Sang. 1991;60(1):34-9
references.pmid: 2053327
references.citation: Transfus Med. 2005 Oct;15(5):371-8
references.pmid: 16202051
references.citation: Transfusion. 2008 May;48(5):1001-26
references.pmid: 18454738
references.citation: Vox Sang. 2013 Jan;104(1):7-11
references.pmid: 22765287
references.citation: Transfusion. 2009 Jun;49(6):1115-25
references.pmid: 19309474
references.citation: Vox Sang. 1983;44(5):312-8
references.pmid: 6858079
references.citation: Transfusion. 2007 Feb;47(2):316-25
references.pmid: 17302779
references.citation: Vox Sang. 2013 Feb;104(2):93-9
references.pmid: 22924987
references.citation: J Hepatol. 2009 Oct;51(4):798-809
references.pmid: 19615780
references.citation: Transfusion. 2001 May;41(5):652-8
references.pmid: 11346702
references.citation: N Engl J Med. 1978 Jun 22;298(25):1379-83
references.pmid: 652005
references.citation: Transfusion. 2004 Sep;44(9):1332-9
references.pmid: 15318857
references.citation: Vox Sang. 2001 Nov;81(4):222-7
references.pmid: 11903997
references.citation: J Infect Dis. 2010 Sep 1;202(5):700-4
references.pmid: 20653444
references.citation: Gut. 2012 Dec;61(12):1744-53
references.pmid: 22267593
references.citation: Hepatology. 2010 Jan;51(1):63-72
references.pmid: 19877170
references.citation: J Hepatol. 2008 Jun;48(6):1022-5
references.pmid: 18436328
references.citation: Hepatology. 1998 Jun;27(6):1736-42
references.pmid: 9620351
references.citation: Transfusion. 2007 Jan;47(1):74-9
references.pmid: 17207233
references.citation: Transfusion. 2007 Oct;47(10):1783-93
references.pmid: 17880602
references.citation: Transfusion. 1990 Jun;30(5):431-2
references.pmid: 2360234
references.citation: Transfusion. 2003 Oct;43(10):1442-8
references.pmid: 14507277
references.citation: J Clin Virol. 2013 Sep;58(1):315-7
references.pmid: 23856167
references.citation: Transfusion. 2011 Aug;51(8):1840-6
references.pmid: 21332731
references.citation: J Clin Microbiol. 2011 May;49(5):1730-7
references.pmid: 21411575
references.citation: Transfusion. 2002 Jul;42(7):869-75
references.pmid: 12375659
references.citation: Transfusion. 2010 Oct;50(10):2080-99
references.pmid: 20738828
references.citation: Vox Sang. 2006 Nov;91(4):281
references.pmid: 17105601
references.citation: World J Hepatol. 2013 Feb 27;5(2):64-73
references.pmid: 23646231
references.citation: Transfusion. 1995 Jan;35(1):5-12
references.pmid: 7998069
references.citation: Transfusion. 2002 Dec;42(12):1592-7
references.pmid: 12473140
references.citation: Clin Infect Dis. 2003 Jul 1;37(1):88-95
references.pmid: 12830413
references.citation: Transfusion. 2009 Feb;49(2):289-300
references.pmid: 19000230
references.citation: Vox Sang. 2006 Oct;91(3):237-43
references.pmid: 16958836
references.citation: Hepatology. 2012 Aug;56(2):434-43
references.pmid: 22271491
references.citation: Transfus Med Hemother. 2014 Jul;41(4):309-25
references.pmid: 25254027
references.citation: J Hepatol. 2005 Mar;42(3):302-8
references.pmid: 15710212
references.citation: Transfusion. 2003 Jun;43(6):788-98
references.pmid: 12757531
references.citation: Hepat Mon. 2013 Mar 17;13(3):e6590
references.pmid: 23675384
references.citation: Vox Sang. 2012 May;102(4):285-93
references.pmid: 22082342
references.citation: Transfusion. 2001 Sep;41(9):1093-9
references.pmid: 11552064
references.citation: Transfus Med. 2008 Dec;18(6):379-81
references.pmid: 19140823
references.citation: Transfus Med. 2011 Feb;21(1):33-41
references.pmid: 20726954
references.citation: Transfusion. 2007 Oct;47(10):1809-15
references.pmid: 17880605
references.citation: Br J Haematol. 1999 Oct;107(1):186-95
references.pmid: 10520040
references.citation: Vox Sang. 2004 Feb;86(2):83-91
references.pmid: 15023176
references.citation: Transfusion. 2013 Jul;53(7):1405-15
references.pmid: 23362802
references.citation: J Hepatol. 2008 Oct;49(4):652-7
references.pmid: 18715666
references.citation: Transfus Med. 2011 Apr;21(2):107-15
references.pmid: 21118317
references.citation: Ann Intern Med. 1986 Apr;104(4):488-95
references.pmid: 3006567
references.citation: Transfusion. 2007 Jul;47(7):1197-205
references.pmid: 17581154
references.citation: Blood Transfus. 2013 Apr;11(2):203-16
references.pmid: 23356973
references.citation: Semin Immunopathol. 2013 Jan;35(1):39-52
references.pmid: 22829332
references.citation: Vox Sang. 2014 Feb;106(2):103-10
references.pmid: 23909571
references.citation: Lancet. 1999 Jan 30;353(9150):359-63
references.pmid: 9950441
references.citation: Transfusion. 2005 Aug;45(8):1247-57
references.pmid: 16078909
references.citation: Vox Sang. 2012 Jan;102(1):82-90
references.pmid: 21933190